Advances in allogeneic hematopoietic stem cell transplantation (HSCT) in malignant and non-malignant diseases result in more long-term survivors, in whom cardiovascular (CV) disease is one leading non-cancer cause of death. This study aimed to evaluate risk factors and subclinical CV organ damage in survivors after HSCT in pediatric age. We enrolled 64 children in a cross-sectional approach 3.3 ± 3.1 years after HSCT. Anthropometric data, laboratory values, office and 24-h ambulatory blood pressure monitoring (ABPM) were evaluated, showing a high prevalence of obesity, hypertension and dyslipidemia. CV organ damage was determined by non-invasive measurements of aortic pulse wave velocity (PWV), left ventricular mass index (LVMI), and carotid intima media thickness (IMT). Increased IMT and elevated PWV reflecting subclinical vascular damage were detected in 48% (IMT) and 6% (PWV) of our population. For IMT, physical activity had a positive impact and was worsened by time after HSCT. Our results show a surprisingly high rate of subclinical CV organ damage and classical risk factors. Therefore, diagnosis and management of well-known CV risk factors belong to clinical care after HSCT.
Introduction
In 2014, 4400 pediatric patients within Europe received a first allogeneic hematopoietic stem cell transplant (HSCT) for malignant or non-malignant diseases [1] . For patients surviving the first 2 years after HSCT the probability of long-term survivorship is greater than 80% (10 years overall survival) [2] . Compared to historical figures the survival advantages derive from better tissue typing with more precise HLA-matching, adaptations respecting the intensity of preparative regimens and treatment of graft vs. host disease (GvHD), and clearly from advances in supportive care [2] . However, despite increasing survival rates in recent years, children have been shown to develop specific late effects that are associated with either the underlying disease or the treatment itself [3] .
There are long-term effects related to the preparative regimens [4, 5] . This is especially true for total body irradiation (TBI)-containing regimens, which lead to a higher rate of secondary malignancies, thyroid malfunctions, growth retardation, and central nervous system complications [6] . In addition, non-malignant diseases (e.g., Fanconi anemia) may contribute to a characteristic spectrum of late effects that are a consequence of disease-specific sequelae not amenable to HSCT [5] .
Apart from these relatively well-described long-term burdens a high incidence of cardiovascular (CV) late effects has been recognized in long-term survivors of HSCT [7] . In fact, death from CV events has become the third leading cause of mortality after malignancies (relapse or secondary cancer) and chronic GvHD [8, 9] . Patients seem to have more premature CV events after allogeneic HSCT as Anette Melk and Rita Beier contributed equally to this work. compared to autologous HSCT [10] . Apart from treatmentassociated CV risk factors (TBI, chronic GvHD) [3, 11] , HSCT survivors may also develop or are even more susceptible to classical risk factors (high blood pressure, hyperlipidemia, obesity, reduced physical activity) that are also present in the general population [12, 13] .
Despite a potentially increased CV risk, major adverse CV events (MACE) are almost absent in children and adolescents in the early years after HSCT [14] . Noninvasive measurements of the vascular system in adults revealed that intima media thickness (IMT), pulse wave velocity (PWV), and left ventricular mass index (LVMI) may act as surrogate endpoints for the onset of MACE [15] [16] [17] . The predictive value of these measurements was confirmed in prospective studies [18, 19] . Comparable prospective studies with outcome parameters such as MACE are non-existent for children due to the very low incidence. Pediatricians, however, have a fundamental interest in evaluating CV risk through non-invasive examinations [20, 21] . In this cross-sectional study, we screened children within the first decade after HSCT by using noninvasive CV assessment tools and found a surprisingly high burden of CV risk factors and subclinical organ damage.
Methods

Study population
In this observational study, 64 patients after HSCT under 18 years of age were enrolled from April 2013 to September 2016. The patients had a minimum follow-up after HSCT of 6 months and were included, if their parents had given informed consent. Patients under 6 years of age at recruitment, with coexisting CV anomalies or anomalies of the limbs preventing diagnostic procedures were not eligible. The study was approved by the institutional review board (#504) and performed according to the Declaration of Helsinki.
Patients' clinical history including underlying disease, transplantation history, previous chemotherapy, TBI (if patients received 4 Gy of TBI they were categorized in chemotherapy based preparative regimen), medication and data about acute and chronic graft vs. host disease (aGvHD, cGvHD) were taken from medical charts. The grading and staging of GvHD was based upon Glucksberg et al. [22] and Filipovic et al. [23] . Further information (family history, physical activity) was retrieved from the patients and their parents.
In order to compare values from children of different age and gender, we calculated standard deviation scores (SDS) for anthropometric and CV measures whenever appropriate and standardized for age [24] [25] [26] [27] . The evaluation of anthropometric laboratory parameters and CV examinations were performed as described before [28] .
Anthropometric and laboratory parameter
Height, weight and waist circumference were measured and SDS values calculated [29, 30] . Overweight or obesity was determined as a BMI between 85. and <95. percentile, and equal to or above the 95. percentile [26] . Waist circumference equal to or exceeding the 90. percentile was considered as increased [27] . Blood and urine samples were analyzed in a central laboratory (Synlab, Heidelberg, Germany) (analyzed values in Suppl. Text A).
Cardiovascular examinations
Aortic pulse wave velocity (PWV)
The PWV assessments were performed in accordance with the recommendations of the Tast Force III on clinical application of arterial stiffness [31] . The oscillometric Vicorder device was used for the measurements (Skidmore Medical Ltd., Bristol, United Kingdom; Version 4) as previously reported [24, 28, 32, 33] .
Intima media thickness (IMT)
Ultrasound examination was performed using an 8-MHz annular array ultrasound imaging system (Siemens AcusonP50 US system, Version 2.1) as described in the Mannheim consensus [24, 33] .
Transthoracic echocardiography
For the determination of left ventricular mass (LVM) we used standard transthoracic projections and the following formula as described before: LVM(g) = 0. 
Ambulatory blood pressure monitoring (ABPM)
Twenty-four hour ABPM was performed by automated blood pressure monitors (Spacelabs Healthcare, Hertford, UK). Evaluations were based on published defintions [36, 37] . Normotension was defined as BP < 95. percentile without antihypertensive treatment; controlled hypertension as BP < 95. percentile with treatment, untreated hypertension as BP > 95. percentile without treatment. Office blood pressure below and ABPM values equal or above the 95. percentile were defined as masked hypertension.
Statistical methods
The statistical analysis was performed using SPSS Version 20.0 (IBM, NY, USA). For the comparison of means of continuous variables t-test was used and for the analysis of categorical variables χ² test was utilized. The Pearson correlation matrix was performed to examine associations between continuous variables. The independent predictive influence of variables were checked by multivariable stepwise linear regression; in which a cutoff of 0.2 was used for entry and 0.05 for removal of variables. All multivariable models were controlled for the influence of gender. The data were normalized for age and height using the LMS method [36] . P-values < 0.05 were regarded significant.
Results
Patient characteristics
Characteristics and transplantation-related information of the 64 patients are summarized in Table 1 . The gender ratio was balanced with 55% male (35/64) participants. The majority of patients (95%) had received their first transplant and were transplanted because of a malignant disease (72%) ( Table 1) . Prior chemotherapy was used in 55% of the patients, which consisted in the majority (88%) of an anthracycline-containing regimen according to the different BFM treatment guidelines applicable to their underlying diseases [39] . In preparation for transplantation, about two thirds of patients received a chemotherapybased and one-third an irradiation-based regimen. Peritransplant immunosuppression consisted of two main approaches. Patients with malignant diseases were mainly treated with anti-thymocyte globulin, ciclosporin A (CsA) and methotrexate, while in non-malignant diseases alemtuzumab, mycophenolate mofetil and CsA were used (Table 1) . At the time of examination, six patients were still on immunosuppressive therapy with either a calcineurin inhibitor (CsA or tacrolimus) or an mTOR inhibitor (sirolimus) for treatment of cGvHD (four patients) or aGvHD (two patients).
Cardiovascular risk factors
Obesity
Based on BMI, 20% of patients were either overweight or obese (Table 2) . Additionally, three patients had a waist circumference equal or above the 90. percentile with a normal BMI. Neither patients with ALL who had received prior corticosteroid treatment nor patients who had received TBI had a higher prevalence of overweight or obesity at the time of investigation. Altogether, a quarter of patients were either overweight, obese or had an increased waist circumference.
Blood pressure
BP and ABPM values are presented in Table 2 and Suppl. Table 1 . Based on office BP measurements, hypertension was diagnosed in 3% (2/64) of patients (Fig. 1a) . Using a combination of office BP and ABPM in a subset of our patients, we identified 24% (11/46) of patients with hypertension; of those, 9 patients had masked hypertension (6 nocturnal hypertension) (Fig. 1b) . Patients with masked hypertension were equally distributed with regard to underlying disease and use of TBI-based vs. chemotherapy based regimen. Additionally, we could not find any influence of the presence of GvHD, but saw in the univariate analysis a significant association between higher diastolic office BP values and elevated IMT values (Suppl. Table 3 ).
Plasma lipids
A high prevalence of dyslipidemia was present in this patient group of 23% (Table 2) , especially in patients on thyroid replacement therapy (5/12 patients). In addition, up to one third of the patients had at least one cholesterol value in the borderline category (Suppl. Table 2 , Suppl. Text B).
Glucose levels
In our population, none of the patients had impaired glucose tolerance or diabetes mellitus, based on clinical evaluation and/or lab values at time of evaluation.
Physical activity
Seventy percent of the patients were physically active at least 1 h per week (Table 2 ). In patients with cGvHD the level of physical activity was reduced to 1.25 ± 1.17 h, in the case of extensive cGvHD this reduction was even more pronounced with only 0.67 ± 1.2 h per week.
Microinflammation
In one third of patients, we found increased levels for hsCRP (Table 2 ). There were no associations to a history of TBI, VOD or aGvHD, whereas five of the eight patients with cGvHD had increased hsCRP levels (details of ferritin and anaemia values are given in Suppl. Text C).
Subclinical organ damage
Renal function
Using the creatinine-cystatin C-based CKID equation [38] , the estimated glomerular filtration rate (eGFR) was 109 ± 18 ml/min/1.73 m 2 (Table 3) Figure 2 shows the distribution of PWV SDS values with 4 patients (6%) displaying values above the 95. percentile (Table 3 ). The univariate analysis (Suppl. Table 3) showed a significant positive association for waist SDS and age at HSCT. This was confirmed in multivariable analysis showing that higher waist circumference and time of HSCT before the age of 12 years were independently associated with elevated PWV SDS (Table 4) . Figure 3 shows the IMT SDS values: 48% of the patients displayed IMT values above the 95. percentile (Table 3) . Univariate analysis (Suppl. Table 3 ) showed positive correlations for time since transplantation, diastolic office blood pressure, waist circumference, and female gender. At inclusion in the study 13.9 ± 4.5 (6-25.6)
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At diagnosis of underlying disease Fig. 3 ).
Echocardiographic results
Left ventricular hypertrophy was present in 11% (3/28) of the investigated patients (Table 3 and Fig. 4) . A reduced ejection fraction was found in two patients. The univariate analysis (Suppl . Table 3 ) for the LVMI revealed significant positive associations for the diastolic daytime BP in ABPM, and negative correlations for the presence of a malignant underlying disease, anthracycline therapy and VOD. Multivariable analysis revealed that anthracycline therapy and history of VOD were associated with lower LVMI (Table 4) .
Discussion
We could show in our study cohort a dramatic burden of asymptomatic subclinical organ damage and a very high prevalence of CV risk factors in survivors of pediatric [56] can be found in Suppl. Table 2 . c Hyperparathyroidism defined as PTH > 39 pg/ml in girls and >36 pg/ ml in boys younger than 16 years; and > 72 pg/ml for both gender older than 16 years. d Definition according to Krug et al. [57] HSCT. Aortic stiffening with elevated PWV was detected in 6%, atherosclerosis with increased IMT values in 48%, left ventricular hypertrophy in 11% and decreased left ventricular ejection fraction in 7% of transplanted children. Classical factors such as adiposity, arterial hypertension, mild renal impairment with microalbuminuria, microinflammation, dyslipidemia, and low or even absent physical activity were observed in high prevalence in our cohort. Abdominal adiposity and low physical activity turned out to determine PWV and IMT, which are known to be associated with subsequent cardiovascular events [41, 42] .
PWV reflects progression of arterial stiffness and shows the degree of arteriosclerosis [43] . No comparable studies using normalized PWV data in children after HSCT are available. In our cohort, we found that younger age at transplantation was significantly associated with elevated PWV suggesting a higher vulnerability towards cardiovascular injury at younger age. Abdominal adiposity detected by waist circumference turned out to be an independent risk factor for arterial stiffness. Adult survivors of pediatric haematologic cancer had a higher rate of increased PWV compared to age-matched healthy controls [44] . Central adiposity has been shown to be more associated with cardio-metabolic comorbidities than BMI [29] . We think that PWV measurement should be included in the clinical aftercare of survivors of HSCT in pediatric age especially if they have CV risk factors, e.g.., obesity or increased waist circumference.
Early atherosclerosis can be measured by IMT. Current guidelines in adults emphasize that absolute values, but not treatment-induced changes in IMT are associated with increased CV risk [45] . We could show that physical activity is beneficial in the prevention of atherosclerosis by demonstrating significantly lower IMT SDS in these children. This is in line with a recently published meta-analysis indicating that exercise reduces carotid IMT in obese children [46] . Similarly, carotid IMT reduction was 10-23% among physically active individuals compared to their inactive peers [47] . The sports programs investigated by the meta-analysis commonly consisted of 3 sessions of 1-h training per week [46] . This is comparable to the mean level of exercise (3 h/week) described in our cohort. However, one third of the children in our study did not perform any kind of physical activity rendering them at higher CV risk. This overall low rate of physical activity is comparable to other pediatric groups surviving life-threatening diseases, for which reintegration in sports programs has been described as difficult [48] . Therefore, physical activity, even at a minimum level, can be beneficial for the arterial wall to prevent atherosclerotic changes.
Apart from obesity and low physical activity, our cohort displayed other important CV risk factors. Hypertension was apparent in about one quarter of our patients and was mainly discovered by use of ABPM. This is in contrast to a report of pediatric ALL survivors 9 years after HSCT that were treated with a TBI based regimen [49] . In these patients hypertension based on office BP measurements was found in 42% of patients. In another study including patients with different diseases and preparative regimens the prevalence of hypertension was 15% [50] .
Cardiac remodeling was present in almost twenty percent of children expressed as either elevated LVMI or decreased left ventricular function. In the univariate analysis of our data, concordant with other studies, higher diastolic blood pressure was significantly associated with elevated LVMI [51] . In the multivariable analysis former anthracycline therapy and a history of VOD were predictive of lower LVMI. By cardiac magnetic resonance imaging, Neilan et al. had shown that anthracycline exposure resulted in a lower heart weight, which had a significant impact on subsequent MACE development [52] . The pathophysiology of VOD arises from endothelial cell damage due to the transplantation conditioning regimen [53] . These mechanisms are complex and begin with injury to sinusoidal endothelial cells and hepatocytes due to toxic metabolites created by chemotherapeutic agents and ionizing radiation [53] . We think that the cardiac damage could be induced by a combination of chemotherapy, radiation and VOD as a critical illness, but further investigations are warranted.
The rate of dyslipidemia in one quarter of our patients is higher than what was reported for another pediatric HSCT cohort, in which only 15.8% had dyslipidemia [13] . A cohort of adult patients displayed a higher frequency with 44% 5 years after HSCT [12] . To our surprise dyslipidemia was highly prevalent in patients on thyroid hormone replacement therapy with normal TSH and fT4 values. Previously, this had been reported in patients with untreated or subclinical hypothyroidism and was corrected after replacement therapy [53] , which in our cohort was not seen. Dyslipidemia in our cohort had no influence on PWV or IMT, but a longer follow-up may show more subclinical organ damage in untreated patients. An early treatment with statins may be considered when several CV risk factors are present, especially in patients with endocrine disorders.
Microinflammation was present in 30% of patients. In our mixed cohort, no association of hsCRP with subclinical target organ damage could be demonstrated. Other studies have shown increased hsCRP levels in HSCT and non-HSCT survivors of childhood cancer [49, 55] , so the impact of this parameter on cardiovascular target organ damage remains unclear.
The greatest strength of the present study is the large number of patients which were extensively evaluated for CV risk factors and subclinical target organ damage with age adjusted SDS for PWV and IMT. We could show that this special patient group has a high prevalence of different CV risk factors (hypertension, dyslipidemia, obesity) which has to be taken into account for their lifelong care. The critical situation for this patient group is that half of them already have increased IMT SDS values as a burden for their future. We are aware that longitudinal studies have to provide further data on the development of such changes over time and their predictive value in this special patient group. However, we feel that at this point in time we have enough evidence to recommend screening for CV risk factors on a regular basis with an additional work-up using more tedious examinations like PWV, IMT, and echocardiography in cases with a high load of CV risk factors. The main limitation is that we have many influences on cardiac risk profile in the patient group, e.g., different preparative regimens (chemotherapy vs. TBI) for HSCT, antracycline exposure, and underlying diseases (malignant 
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Creatinine and non-malignant). The real additive burden of HSCT in comparison to chemotherapy remains unknown. Although we have shown that time since HSCT is one of the main factors for elevated PWV and IMT, the longitudinal development over time is still unknown. Since the main studies are cross-sectional, prospective longitudinal studies are warranted to evaluate whether these results can be corroborated for longer follow-up. 
